|
4-methyl-2-(4-methylphenyl)-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
4-methyl-2-phenyl-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
Depiction based on curated SMILES
N
N
N
O
N
O
N
O
CH
3
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
6-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-(pyridin-4-yl)pyridazin-3-amine |
Depiction based on curated SMILES
N
N
N
N
H
CH
3
N
N
O
O
S
CH
3
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
N-(1,3-benzodioxol-5-ylmethyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]-4-piperidinecarboxamide |
Depiction based on curated SMILES
O
O
HN
N
H
O
S
O
O
N
O
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
N-(furan-2-ylmethylcarbamoyl)-2-(4-oxobenzo[g]quinazolin-3-yl)acetamide |
Depiction based on curated SMILES
O
N
H
O
HN
O
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
[2-[[(1R,2R)-2-methylcyclohexyl]carbamoylamino]-2-oxoethyl] 4-oxo-3-phenylphthalazine-1-carboxylate |
Depiction based on curated SMILES
N
N
O
O
N
H
H
H
H
3
C
O
N
H
O
O
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
1'-butyl-4'-(nitromethyl)-1',4'-dihydro-2,3'-biquinoline |
Depiction based on curated SMILES
_
O
O
+
N
H
3
C
N
N
|
Shigella |
VirF |
Preclinical (in vitro) |
Koppolu V, et al. 2013. Infect Immun |
|
5-Hydroxyindole |
Depiction based on curated SMILES
OH
N
H
|
Salmonella Shigella |
TTSS (SPI-1 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
McShan AC, et al. 2016. ChemMedChem Dey S, et al. 2017. ChemMedChem |
|
4-Aminoquinaldine |
Depiction based on curated SMILES
CH
3
NH
2
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dey S, et al. 2017. ChemMedChem |
|
3,5-di(3-pyridylmethyl)-1,3,5-thiadiazinane-2-thione |
Depiction based on curated SMILES
N
N
S
S
N
N
|
Shigella |
VirF |
Preclinical (in vitro) |
Hurt JK, et al. 2010. J Biomol Screen |
|
| | |